E-LIB Suche - Ergebnisse für: Bermel, R.A.

1

Factors associated with treatment escalation among MS speci..:

Saposnik, G. ; Andhavarapu, S. ; Fernández, Ó....
Multiple Sclerosis and Related Disorders. 58 (2022) - p. 103404 , 2022

Link: https://doi.org/10.1016/..

2

Cognitive processing speed in multiple sclerosis clinical p..:

Macaron, G. ; Baldassari, L. E. ; Nakamura, K....
European Journal of Neurology. 27 (2020) 7 - p. 1238-1249 , 2020

Link: https://doi.org/10.1111/..

3

Multiple Sclerosis Performance Test: validation of self‐adm..:

Rao, S. M. ; Galioto, R. ; Sokolowski, M....
European Journal of Neurology. 27 (2020) 5 - p. 878-886 , 2020

Link: https://doi.org/10.1111/..

4

Fingolimod first-dose effects in patients with relapsing mu..:

Bermel, R.A. ; Hashmonay, R. ; Meng, X....
Multiple Sclerosis and Related Disorders. 4 (2015) 3 - p. 273-280 , 2015

Link: https://doi.org/10.1016/..

5

Early Tolerability and Safety of Fingolimod in Clinical Pra..:

Ontaneda, D. ; Hara-Cleaver, C. ; Rudick, R...
Neurology. 78 (2012) Meeting Abstracts 1 - p. P04.130-P04.130 , 2012

Link: https://doi.org/10.1212/..

6

Phase 1 Clinical Trial of Autologous Mesenchymal Stem Cell ..:

Cohen, J. ; Bar-Or, A. ; Bermel, R....
Neurology. 78 (2012) Meeting Abstracts 1 - p. S30.002-S30.002 , 2012

Link: https://doi.org/10.1212/..

7

Phase 1 Clinical Trial of Autologous Mesenchymal Stem Cell ..:

Cohen, J. ; Bar-Or, A. ; Bermel, R....
Neurology. 78 (2012) Meeting Abstracts 1 - p. IN8-2.003-IN8-2.003 , 2012

Link: https://doi.org/10.1212/..

8

GABA-fMRI Activation Volume Correlation Suggests GABA Is a ..:

Bhattacharyya, P. ; Bermel, R. ; Phillips, M....
Neurology. 78 (2012) Meeting Abstracts 1 - p. P03.066-P03.066 , 2012

Link: https://doi.org/10.1212/..

9

Cardiovascular Effects and Safety of Fingolimod in Clinical..:

Bermel, R. ; Ontaneda, D. ; Hara-Cleaver, C...
Neurology. 78 (2012) Meeting Abstracts 1 - p. P04.138-P04.138 , 2012

Link: https://doi.org/10.1212/..

10

Restricted Diffusion Preceding Gadolinium Enhancement in Ac..:

Hyland, M. ; Bermel, R. ; Cohen, J.
Neurology. 78 (2012) Meeting Abstracts 1 - p. P03.052-P03.052 , 2012

Link: https://doi.org/10.1212/..

11

FP39-WE-02 A 15-year follow-up study to identify early pred..:

Bermel, R.A. ; Rudick, R.A. ; Hyde, R....
Journal of the Neurological Sciences. 285 (2009) - p. S119 , 2009

Link: https://doi.org/10.1016/..

12

An Evaluation of the Robustness of Tract-based Measures of ..:

Li, M. ; Lin, J. ; Sakaie, K....
NeuroImage. 47 (2009) - p. S48 , 2009

Link: https://doi.org/10.1016/..

13

Stereoselective inhibition of dopaminergic activity by gamm..:

Schiffer, W.K ; Gerasimov, M.R ; Bermel, R.A..
Life Sciences. 66 (2000) 13 - p. PL169-PL173 , 2000

Link: https://doi.org/10.1016/..

14

Characterisation of MS phenotypes across the age span using..:

Dahlke, F ; Arnold, DL ; Aarden, P...
doi:10.1177/1352458520988637. , 2023

Link: https://doi.org/10.1177/..

15

Shorter infusion time of ocrelizumab:Results from the rando..:

Hartung, H. P ; Berger, T ; Bermel, R. A...
Hartung , H P , Berger , T , Bermel , R A , Brochet , B , Carroll , W M , Holmøy , T , Karabudak , R , Killestein , J , Nos , C , Patti , F , Ross , A P , Vanopdenbosch , L , Vollmer , T , Buffels , R , Garas , M , Kadner , K , Manfrini , M , Wang , Q & Freedman , M S 2020 , ' Shorter infusion time of ocrelizumab : Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis ' , Multiple Sclerosis and Related Disorders , vol. 46 , 102492 . https://doi.org/10.1016/j.msard.2020.102492. , 2020

Link: https://research.vumc.nl..